Purpose:The 8-year medical education program(EYMEP)is China's path to training high-level medical talents.In retrospect,this study systematically reviewed the developmental process of China's EYMEP.The status ...Purpose:The 8-year medical education program(EYMEP)is China's path to training high-level medical talents.In retrospect,this study systematically reviewed the developmental process of China's EYMEP.The status quo and characteristics,and threats and challenges,were analyzed,along with the program’s prospects.Design/Approach/Methods:This study analyzed relevant textual materials and policy documents dating back to the time of hosting of China's EYMEP,as well as conducted various specific interviews and field trips.Findings:The exploration of China's high-level medical talent training has been conducted over a century.EYMEP can be divided into five periods:the Only Host Period,the Duplication Pilot Host Period,the Expansion Period,the Joint Exploration Period,and the In-Depth Promotion Period.Currently,there are 14 universities and institutes hosting the EYMEP approved by the Ministry of Education of the People's Republic of China.However,they differ greatly in training ideas and goals,enrollment processes,and training phases.China's EYMEP is faced with some external threats and internal challenges.In the future,China's EYMEP should consider five aspects.Originality/Value:In the new era of the reform and development of China's medical education,a systematic review of the development of EYMEP in China is of great significance to the promotion of high-level medical talent training in China.Meanwhile,the exploration course of China's highlevel medical talent training represented by the EYMEP may be an enlightenment for other countries,especially developing countries like China,in their training of high-level medical talents.展开更多
目的研究扶正化瘀肝糖综合治疗方案治疗乙型肝炎后肝硬化合并糖代谢异常的临床疗效。方法采用随机对照临床试验,将乙型肝炎后肝硬化合并糖代谢异常的患者随机分为治疗组(68例)和对照组(74例),分别采用扶正化瘀肝糖综合治疗方案和中西医...目的研究扶正化瘀肝糖综合治疗方案治疗乙型肝炎后肝硬化合并糖代谢异常的临床疗效。方法采用随机对照临床试验,将乙型肝炎后肝硬化合并糖代谢异常的患者随机分为治疗组(68例)和对照组(74例),分别采用扶正化瘀肝糖综合治疗方案和中西医常规综合治疗方案治疗3个月,检测两组治疗前后空腹血糖(FPG)、糖负荷后2 h血糖(2 h PG)及空腹胰岛素(FINS)等指标,计算胰岛素抵抗指数(HOMA- IR),并记录治疗前后证候评分情况,通过统计分析,分别评定其中医证候疗效和糖代谢异常疗效。结果治疗后两组2 h PG较治疗前均显著下降(P<0.01),治疗组治疗前后FPG差值及HOMA-IR差值与对照组比较差异有统计学意义(P<0.05),治疗组中医证候好转率(85.3%)和糖代谢异常的总有效率(80.9%)均明显优于对照组(64.9%,62.2%),差异有统计学意义(P<0.01,P<0.05)。结论扶正化瘀肝糖综合治疗方案具有改善乙型肝炎后肝硬化合并糖代谢异常患者中医证候和糖代谢异常的疗效。展开更多
基金supported by the Key Project for Medical Education Research in 2018 of the Medical Education Branch of the Chinese Medical Association and Specialty Committee of Medical Education in China Association of Higher Education(2018A-N02095).
文摘Purpose:The 8-year medical education program(EYMEP)is China's path to training high-level medical talents.In retrospect,this study systematically reviewed the developmental process of China's EYMEP.The status quo and characteristics,and threats and challenges,were analyzed,along with the program’s prospects.Design/Approach/Methods:This study analyzed relevant textual materials and policy documents dating back to the time of hosting of China's EYMEP,as well as conducted various specific interviews and field trips.Findings:The exploration of China's high-level medical talent training has been conducted over a century.EYMEP can be divided into five periods:the Only Host Period,the Duplication Pilot Host Period,the Expansion Period,the Joint Exploration Period,and the In-Depth Promotion Period.Currently,there are 14 universities and institutes hosting the EYMEP approved by the Ministry of Education of the People's Republic of China.However,they differ greatly in training ideas and goals,enrollment processes,and training phases.China's EYMEP is faced with some external threats and internal challenges.In the future,China's EYMEP should consider five aspects.Originality/Value:In the new era of the reform and development of China's medical education,a systematic review of the development of EYMEP in China is of great significance to the promotion of high-level medical talent training in China.Meanwhile,the exploration course of China's highlevel medical talent training represented by the EYMEP may be an enlightenment for other countries,especially developing countries like China,in their training of high-level medical talents.
文摘目的研究扶正化瘀肝糖综合治疗方案治疗乙型肝炎后肝硬化合并糖代谢异常的临床疗效。方法采用随机对照临床试验,将乙型肝炎后肝硬化合并糖代谢异常的患者随机分为治疗组(68例)和对照组(74例),分别采用扶正化瘀肝糖综合治疗方案和中西医常规综合治疗方案治疗3个月,检测两组治疗前后空腹血糖(FPG)、糖负荷后2 h血糖(2 h PG)及空腹胰岛素(FINS)等指标,计算胰岛素抵抗指数(HOMA- IR),并记录治疗前后证候评分情况,通过统计分析,分别评定其中医证候疗效和糖代谢异常疗效。结果治疗后两组2 h PG较治疗前均显著下降(P<0.01),治疗组治疗前后FPG差值及HOMA-IR差值与对照组比较差异有统计学意义(P<0.05),治疗组中医证候好转率(85.3%)和糖代谢异常的总有效率(80.9%)均明显优于对照组(64.9%,62.2%),差异有统计学意义(P<0.01,P<0.05)。结论扶正化瘀肝糖综合治疗方案具有改善乙型肝炎后肝硬化合并糖代谢异常患者中医证候和糖代谢异常的疗效。
